Men smoking waterpipes outside in the evening

Many countries in low-resource settings face significant hurdles in enforcing anti-tobacco laws, enabling farmers to transition to alternative crops, and fighting the smuggling of chemicals and tobacco products.

Close up of a image scan of a cancer patient undergoing an imaging examination (MRI), with health practitioners in the background
Woman in white blouse reaching for medication on a shelf

Marking International Nurses Day on 12 May, Howard Catton explains how investing early in nurses’ education on antibiotics can help address the growing problem of antimicrobial resistance.

Woman from Latin America on the left, smiling; man wrapped in scarf symbolising the LGBTQ+ movement on the right, smiling; and "close the care gap" logo of the 2022 World Cancer Day campaign

Together, UICC, its members and partners and the entire cancer community made the new World Cancer Day “Close the care gap” campaign a resounding success.

Three women carrying baskets on their back, walking on a mountain trail

Marking World Ovarian Cancer Day on 8 May, Clara MacKay reveals the chasm of inequities in ovarian cancer as incidence and mortality rise particularly for already disadvantaged populations.

Election of the 2018-2020 board at the 2018 General Assembly which took place in conjunction with the 2018 World Cancer Congress in Kuala Lumpur, Malaysia

UICC members are invited to play a role in shaping the future of the organisation by nominating candidates for the Board of Directors 2022-2024 and for President-elect.

Viatris is a global pharmaceutical company, empowering people worldwide to live healthier at every stage of life. Viatris provides access to medicines, advances sustainable operations, develops innovative solutions and leverages collective expertise to connect more people to more products and services through their Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable diseases (NCDs) and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products.  Among NCDs, cancer is one of the leading causes of death worldwide, and the global cancer burden is increasing. Viatris is committed to playing its role in improving access and supporting the UICC global initiative to bridge the gap in cancer care and reduce the burden of cancer globally.

Subscribe to